Dianthus Therapeutics Inc. (DNTH) — Financial Flexibility Index
Dianthus Therapeutics Inc. (DNTH) has a Financial Flexibility Index of -0.63x as of March 2026. Free cash flow of $-28.85 Million (operating CF $-28.86 Million minus capex $10.00K) represents -1% of total liabilities ($45.57 Million). Check Dianthus Therapeutics Inc. (DNTH) strategic asset index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Dianthus Therapeutics Inc. Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Dianthus Therapeutics Inc. across 10 annual periods. See Dianthus Therapeutics Inc. (DNTH) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Dianthus Therapeutics Inc. (2016–2025)
Year-by-year free cash flow to debt coverage for Dianthus Therapeutics Inc.. For the full company profile including market capitalisation, see market value of Dianthus Therapeutics Inc..
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.43x | $-128.85 Million | $-129.06 Million | $37.52 Million | ▲ +5.3% |
| 2024 | -3.63x | $-78.08 Million | $-78.18 Million | $21.53 Million | ▼ -3.9% |
| 2023 | -3.49x | $-36.75 Million | $-36.86 Million | $10.54 Million | ▼ -14.0% |
| 2022 | -3.06x | $-28.93 Million | $-29.07 Million | $9.45 Million | ▲ +9.3% |
| 2021 | -3.38x | $-58.27 Million | $-59.53 Million | $17.26 Million | ▲ +6.0% |
| 2020 | -3.59x | $-63.62 Million | $-64.02 Million | $17.71 Million | ▼ -35.1% |
| 2019 | -2.66x | $-54.04 Million | $-57.10 Million | $20.32 Million | ▲ +9.3% |
| 2018 | -2.93x | $-34.21 Million | $-41.89 Million | $11.66 Million | ▲ +39.5% |
| 2017 | -4.84x | $-20.06 Million | $-22.26 Million | $4.14 Million | ▼ -74.4% |
| 2016 | -2.78x | $-6.39 Million | $-6.53 Million | $2.30 Million | — |